Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
52,654,712
-
Share change
-
-1,501,357
-
Total reported value
-
$6,793,004,689
-
Put/Call ratio
-
104%
-
Price per share
-
$128.88
-
Number of holders
-
171
-
Value change
-
-$266,902,917
-
Number of buys
-
99
-
Number of sells
-
73
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2021
As of 31 Mar 2021,
Ascendis Pharma A/S - ADR (ASND) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,654,712 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, EVENTIDE ASSET MANAGEMENT, LLC, and Vivo Capital, LLC.
This page lists
172
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.